Across TCGA pan-cancer cohorts, CNN2P12 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CNN2P12’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CNN2P12 RNA is repressed in tumor relative to normal tissue. In most cancer types CNN2P12 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

KIRC, STAD, and COAD are the cancer types where CNN2P12 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CNN2P12 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	−0.022	.007	5	view →
STAD	All	II,III,IV	+0.055	.006	4	view →
COAD	All	All	+0.089	.029	1	view →
THCA	Female	III,IV	+0.085	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: CNN2P12 RNA expression & survival · all CNN2P12 data types